Financial News
Press Releases about Revive Therapeutics Ltd
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
Revive Therapeutics Provides Corporate Update
March 12, 2024
Via GlobeNewswire
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
Revive Therapeutics Explores the Use of Bucillamine for Long COVID
February 01, 2024
Via GlobeNewswire
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
![](https://ml.globenewswire.com/media/495ebaf7-944d-442b-bb09-8e0c4ccdb88a/small/revive-therapeutics-png.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.